Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose dexmedetomidine in pediatric cardiac surgery anesthesia
ChiCTR1800017819Phase 4Not yet recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Cardiovascular Malformation (CVM) (3 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoints: Hemodynamic index, S-100β and 9 more. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR1800017819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017819.